Basel, Switzerland, 2006/03/07
Genedata announces the expansion of its collaboration with Bayer HealthCare to include multiple sites in Germany and the US. Genedata will deliver a software solution for characterizing targets and biomarkers.
“Genedata have helped resolve bottlenecks in our research processes, an achievement reflecting their sound grasp of drug discovery”, says Professor Andreas Busch, Head of Global Drug Discovery, Bayer HealthCare. The collaboration has expanded to complement the activities of Bayer HealthCare’s target and biomarker research program. Biomarkers will help identify compounds likely to be effective at later drug development stages, enabling Bayer HealthCare to focus its attention on the most promising therapeutic leads.
“In addition to strong software functionality, we require scalability and solid result information management”, explained Dr. Joe Catino, Head of Discovery US, Bayer Pharmaceuticals Corp. in West Haven. Genedata’s solutions incorporate industry-standard database technologies with an advanced three tier client-server architecture. This has facilitated efficient deployment and integration with Bayer HealthCare’s global research informatics infrastructure.
“We are delighted that Bayer HealthCare has chosen Genedata’s proven IT solutions to support its target and biomarker research efforts”, says Dr. Othmar Pfannes, Chairman and President of Genedata. Earlier phases of the collaboration have been expanded to create a global research informatics solution for Bayer Healthcare. Dr. Pfannes added, “The collaboration demonstrates the usefulness of Genedata Expressionist® and Genedata Phylosopher® for target identification, diagnostics, toxicology and biomarker studies”.
Contact:
Genedata AG
Dr Tobe Freeman
Manager Public Relations
Maulbeerstrasse 46
4016 Basel, Switzerland
Phone +41 61 697 8510
Fax +41 61 697 7244
tobe.freeman@genedata.com
www.genedata.com
About:
Genedata specializes in discovery informatics for biotech, pharmaceuticals and the life sciences. The Company offers expertise in research informatics combined with open and scalable computational solutions. Our solutions include Genedata Phylosopher® for integrating, structuring, and analyzing research data. Genedata Screener® for high throughput screening analysis. And Genedata Expressionist® for omics data integration, processing and analysis. Founded in 1997 as a privately held spin off from Novartis, Genedata is headquartered in Basel, Switzerland and has branches in Munich (Germany), Boston (USA) and San Francisco (USA). The Company is also represented in Japan, Taiwan and Singapore. For more information about Genedata, please visit: www.genedata.com.
Bayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the health care and medical products industry based in Leverkusen/Germany. In 2004, the Bayer HealthCare subgroup generated sales amounting to some 8.5 billion Euro. Bayer HealthCare employed 35,300 people worldwide in 2004. The company combines the global activities of the divisions Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. Since January 1, 2006 the new Pharmaceutical Division consists of the former Biological Products and Pharmaceutical Division and now comprises three business units: Hematology/Cardiology, Oncology and Primary Care. Bayer HealthCare’s aim is to discover and manufacture innovative products that will improve human and animal health worldwide. The products enhance well-being and quality of life by diagnosing, preventing and treating diseases.
Related Files:
Download PDF version